Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva to Buy Cephalon for $6.8 Billion, Topping Valeant Bid
Teva to Buy Cephalon for $6.8 Billion, Topping Valeant Bid
Teva to Buy Cephalon for $6.8 Billion, Topping Valeant Bid
Submitted by
admin
on May 2, 2011 - 9:14am
Source:
Bloomberg
News Tags:
Teva Pharmaceuticals
Cephalon
Valeant Pharmaceuticals
M&A
Headline:
Teva to Buy Cephalon for $6.8 Billion, Topping Valeant Bid
Do Not Allow Advertisers to Use My Personal information